Keller Bailey N, Hajnal Andras, Browning Kirsteen N, Arnold Amy C, Silberman Yuval
Neural and Behavioral Sciences, Penn State College of Medicine, Hershey, PA, United States.
Front Behav Neurosci. 2022 Mar 7;16:801825. doi: 10.3389/fnbeh.2022.801825. eCollection 2022.
The neurobiological mechanisms that regulate the development and maintenance of alcohol use disorder (AUD) are complex and involve a wide variety of within and between systems neuroadaptations. While classic reward, preoccupation, and withdrawal neurocircuits have been heavily studied in terms of AUD, viable treatment targets from this established literature have not proven clinically effective as of yet. Therefore, examination of additional neurocircuitries not classically studied in the context of AUD may provide novel therapeutic targets. Recent studies demonstrate that various neuropeptides systems are important modulators of alcohol reward, seeking, and intake behaviors. This includes neurocircuitry within the dorsal vagal complex (DVC), which is involved in the control of the autonomic nervous system, control of intake of natural rewards like food, and acts as a relay of interoceptive sensory information via interactions of numerous gut-brain peptides and neurotransmitter systems with DVC projections to central and peripheral targets. DVC neuron subtypes produce a variety of neuropeptides and transmitters and project to target brain regions critical for reward such as the mesolimbic dopamine system as well as other limbic areas important for the negative reinforcing and aversive properties of alcohol withdrawal such as the extended amygdala. This suggests the DVC may play a role in the modulation of various aspects of AUD. This review summarizes the current literature on neurotransmitters and neuropeptides systems in the DVC (e.g., norepinephrine, glucagon-like peptide 1, neurotensin, cholecystokinin, thyrotropin-releasing hormone), and their potential relevance to alcohol-related behaviors in humans and rodent models for AUD research. A better understanding of the role of the DVC in modulating alcohol related behaviors may lead to the elucidation of novel therapeutic targets for drug development in AUD.
调节酒精使用障碍(AUD)发展和维持的神经生物学机制复杂,涉及多种系统内和系统间的神经适应性变化。虽然经典的奖赏、专注和戒断神经回路在AUD方面已得到大量研究,但从这一既定文献中得出的可行治疗靶点目前尚未在临床上证明有效。因此,研究AUD背景下未被经典研究的其他神经回路可能会提供新的治疗靶点。最近的研究表明,各种神经肽系统是酒精奖赏、寻求和摄入行为的重要调节因子。这包括背侧迷走神经复合体(DVC)内的神经回路,其参与自主神经系统的控制、食物等自然奖赏的摄入控制,并通过众多肠脑肽和神经递质系统与DVC向中枢和外周靶点的投射之间的相互作用,作为内感受感觉信息的中继站。DVC神经元亚型产生多种神经肽和神经递质,并投射到对奖赏至关重要的目标脑区,如中脑边缘多巴胺系统,以及对酒精戒断的负性强化和厌恶特性很重要的其他边缘区域,如扩展杏仁核。这表明DVC可能在AUD的各个方面的调节中发挥作用。本综述总结了目前关于DVC中神经递质和神经肽系统(如去甲肾上腺素、胰高血糖素样肽1、神经降压素、胆囊收缩素、促甲状腺激素释放激素)的文献,以及它们与人类和啮齿动物AUD研究模型中酒精相关行为的潜在相关性。更好地理解DVC在调节酒精相关行为中的作用可能会有助于阐明AUD药物开发的新治疗靶点。